New blood test could spot deadly lung clots faster
NCT ID NCT06907238
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether new blood markers (TAT, PIC, TM, t-PAIC) can help diagnose and monitor acute pulmonary embolism (a dangerous blood clot in the lungs). Researchers will test 200 newly diagnosed patients and 200 healthy controls to see how accurate these markers are. They will also track patients over time to see if the markers can predict recovery or complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
novel thrombus markers (TAT/PIC/TM/t-PAIC) measured in blood
What this could lead to
If successful, this could lead to a faster, non-invasive way to diagnose and monitor acute pulmonary embolism, potentially saving lives.
What could go wrong
This is an early-stage observational study, not a treatment trial. The markers may not prove accurate enough for routine use, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.